OBJECTIVE Chemerin is an adipokine that affects adipogenesis and glucose homeostasis
in adipocytes and increases with BMI in humans. This study was aimed at investigating the …

OBJECTIVE Chemerin is a recently discovered hepatoadipokine that regulates adipocyte
differentiation as well as chemotaxis and activation of dendritic cells and macrophages …

Chemerin is a chemoattractant adipokine that regulates adipogenesis and may induce
insulin resistance. Chemerin serum concentrations are elevated in obese, insulin-resistant …

Obesity, characterized by an excess of adipose tissue, is an established risk factor for
cardiovascular disease and type 2 diabetes. Different mechanisms linking obesity with these …

Chemerin, a recognized chemoattractant, is expressed in adipose tissue and plays a role in
adipocytes differentiation and metabolism. Gender-and adipose tissue-specific differences …

Metabolic syndrome is a global public health problem and predisposes individuals to
obesity, diabetes and cardiovascular disease. Although the underlying mechanisms remain …

To explore a novel adipokine, we screened adipocyte differentiation-related gene and found
that TIG2/chemerin was strongly induced during the adipocyte differentiation. Chemerin was …

Soluble protein hormones are key regulators of a number of metabolic processes, including
food intake and insulin sensitivity. We have used a signal sequence trap to identify genes …

Chemerin has recently been characterized as a novel adipokine playing a crucial role in
adipocyte differentiation and insulin signalling. In the current study, the impact of insulin …

Chemerin is an adipokine with important regulatory roles in adipogenesis. In humans, serum
total chemerin (ie prochemerin plus chemerin) levels are positively associated with body …